Lemaitre Vascular Inc (LMAT)
Sector: Healthcare
Industry: Surgical & Medical Instruments & Apparatus
Country: United States
Exchange: NASDAQ
Market cap: $1.80B
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Latest financial period: June 30, 2026
Filed with the SEC: August 5, 2026
Estimated earnings date: November 5, 2026
Profit #450 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 70.2% | 70.0% | 68.5% | 70.4% |
Growth #378 of 1484 companies
Payout #664 of 1484 companies
Safety #216 of 1484 companies
Price #771 of 1484 companies
